TINGTING LI

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology SAINT LOUIS, MO NPI 1831154053

General Payments — all program years on this page

$61,143.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,110.22 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $4,443.503
Food and Beverage $923.4811
Travel and Lodging $740.163
Education $3.081

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $93.781
2020 $3,680.001
2021 $4,597.095
2022 $30,348.1531
2023 $16,313.8020
2024 $6,110.2218

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087143100 Novartis Pharmaceuticals Corporation $3,300.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087143128 Novartis Pharmaceuticals Corporation $139.99 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115736755 GlaxoSmithKline, LLC. $64.93 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115755263 GlaxoSmithKline, LLC. $31.02 11/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1115883124 GlaxoSmithKline, LLC. $272.46 12/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116327558 GlaxoSmithKline, LLC. $55.65 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116420849 GlaxoSmithKline, LLC. $123.23 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116435621 GlaxoSmithKline, LLC. $19.88 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116470414 GlaxoSmithKline, LLC. $436.68 11/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116661121 GlaxoSmithKline, LLC. $46.38 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117611017 Amgen Inc. $643.50 05/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141508535 CALLIDITAS THERAPEUTICS US INC. $126.46 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141508537 CALLIDITAS THERAPEUTICS US INC. $29.54 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141521927 CALLIDITAS THERAPEUTICS US INC. $116.04 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141528059 CALLIDITAS THERAPEUTICS US INC. $500.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1149920936 Travere Therapeutics, Inc. $3.08 06/04/2024 Education Undisputed 01/23/2026 View at CMS
1149920940 Travere Therapeutics, Inc. $145.59 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150686219 Aurinia Pharma U.S., Inc. $55.79 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.